SHS Gesellschaft für Beteiligungsmanagement mbH

Portfolio News Current page: 4

5. August 2021 - Newsletter, Portfolio News

Experienced and well-connected: Dr Alan Levy becomes Chairman of the Board of Salvia BioElectronics

With the appointment of Dr. Alan Levy as Chairman of the Board, the Dutch growth company Salvia BioElectronics brings profound life science expertise and decades of experience to the team. Dr Levy has successfully exited four out of five early-stage healthcare companies and also sits on the board of Intuitive Surgical. Salvia develops electromedical neurostimulation […]

Read more
29. April 2021 - Newsletter, Portfolio News

On course for growth despite pandemic: Tyromotion, leading manufacturer of technology-based rehabilitation equipment

Despite the Corona pandemic, the high-tech company Tyromotion GmbH reports considerable success. Tyromotion develops state-of-the-art rehabilitation devices, among others for MS patients and stroke patients. Thanks to state-of-the-art robotics, sensor technology and virtual reality, the rehabilitation process becomes more intensive and the patient sees successes more quickly. The concept also convinced customers in Australia, where […]

Read more
29. April 2021 - Newsletter, Portfolio News

Danish specialist clinic for epilepsy relies on AI-based diagnostic system from Neuro Event Labs

Neuro Event Labs Oy is a leading healthtech company in the field of AI-based diagnosis and monitoring of epilepsy patients. Now the SHS portfolio company announces an extensive cooperation with Filadelfia Epilepsy Hospital in Dianalund. The renowned specialist clinic for epilepsy patients in western Denmark will use the AI-based diagnostic tool Nelli Pro on all […]

Read more
29. April 2021 - Newsletter, Portfolio News

New CEO at active ingredient specialist AMW to drive international expansion

The successful specialty pharmaceutical company AMW GmbH is expanding its management team and bringing experience and leadership to its new CEO, Dr. Konstantin Petropoulus. With his many years of expertise, the molecular biologist with an MBA is to help strengthen AMW’s global presence. In addition, Dr. Petropoulus will expand the drug delivery system pipeline with […]

Read more
29. April 2021 - Newsletter, Portfolio News

c-LEcta receives EXCiPACT certification: accolade for high quality standard

With the internationally recognised EXCiPACT certification, the globally successful biotech company c-LEcta GmbH from Leipzig receives confirmation of its high quality standards in production and distribution (GMP and GDP). The certificate is recognised worldwide by relevant authorities such as the European Union (EU), the US Food and Drug Administration (FDA) and the UK Medicines and […]

Read more
29. April 2021 - Newsletter, Portfolio News

Successful exit: SHS sells stake in CryLaS, a specialist in laser technology for the healthcare, biotech and semiconductor industries

With pulsed and CW laser systems in the deep UV range, Crystal Laser Systems GmbH enjoys a very good reputation worldwide in the healthcare, biotech and semiconductor sectors. SHS is selling the profitable and rapidly growing company to the investor SIP, which intends to further strengthen the market position of CryLaS with new products and […]

Read more
29. April 2021 - Newsletter, Portfolio News

Novel GFRNMR test from numares guarantees more precise testing of kidney function

numares AG, a leader in NMR metabolomics-based diagnostics, has developed a novel multi-marker approach – GFRNMR – to determine kidney function using simple serum tests. The combination of multiple renal biomarkers can exceed the diagnostic limitations of the established method for estimating GFR (glomerular filtration rate). The assessment of kidney function is extremely important for […]

Read more
29. April 2021 - Newsletter, Portfolio News

Completed study shows clear benefits of SIS high-pressure balloon catheters for calcified and severely calcified heart vessels and in-stent restenosis

“OPN-NC Super High Pressure PTCA-Balloon” is the name of the high-pressure balloon catheter from the Swiss company SIS Medical AG, which achieved comparable, often even higher stent expansion compared to conventional balloon catheters in a successfully completed study on 74 heart patients. At the same time, the treatment success can be achieved in only one […]

Read more
29. December 2020 - Portfolio News

GNA Biosolutions Receives Emergency Use Authorization from German Health Authority BfArM for Rapid Molecular SARS-CoV-2 Batch Testing System

German molecular diagnostics startup GNA Biosolutions has received Emergency Use Authorization (Sonderzulassung) from the German Federal Institute for Drugs and Medical Devices (BfArM) for the GNA Octea SARS-CoV-2 Test System. The new technology developed by GNA Biosolutions enables decentralized COVID-19 rapid tests in approximately 40 minutes without sacrificing sensitivity.

Read more
Previous123
4
5Next